BCTX BRIACELL THERAPEUTICS CORP Capital Structure Changes 8-K Filing 2025 - Equity Offerings On April 24, 2025, BriaCell Therapeutics completed a public offering of 2,005,967 units at $4.50 each, raising approximately $12 million, with additional proceeds from an over-allotment option totaling about $1.8 million, aimed for working capital and business advancements.Get access to all SEC 8-K filings of the BRIACELL THERAPEUTICS CORP